La descarga está en progreso. Por favor, espere

La descarga está en progreso. Por favor, espere

Análisis Costo-Utilidad Del Uso De Adalimumab, Etanercept E Infliximab Para El Tratamiento De La Artritis Psoriásica En Uruguay  Nicolás González-Vacarezza,

Publicada porLidia Acuña Modificado hace 5 años

Presentaciones similares

Presentación del tema: "Análisis Costo-Utilidad Del Uso De Adalimumab, Etanercept E Infliximab Para El Tratamiento De La Artritis Psoriásica En Uruguay  Nicolás González-Vacarezza,"— Transcripción de la presentación:

1 Análisis Costo-Utilidad Del Uso De Adalimumab, Etanercept E Infliximab Para El Tratamiento De La Artritis Psoriásica En Uruguay  Nicolás González-Vacarezza, Pharm, MSc, Eduardo Gehling Bertoldi, MD, MSc, Ana Deminco, Pharm, Graciela González, MD, Miguel Martínez Asuaga, MD  Value in Health Regional Issues  Volume 5, Pages (December 2014) DOI: /j.vhri Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

2 Figura 1 Esquema simplificado de parte de la estructura del modelo. Los números 1 y 2 indican que esas ramas del modelo se repiten en los nodos indicados. PASI, Psoriasis Area Severity Index; PASI 75, logra una reducción del 75% en el Psoriasis Area Severity Index respecto al valor basal; PsARC, Psoriatic Arthritis Response Criteria. Value in Health Regional Issues 2014 5, 58-64DOI: ( /j.vhri ) Copyright © 2014 International Society for Pharmacoeconomics and Outcomes Research (ISPOR) Terms and Conditions

Descargar ppt "Análisis Costo-Utilidad Del Uso De Adalimumab, Etanercept E Infliximab Para El Tratamiento De La Artritis Psoriásica En Uruguay  Nicolás González-Vacarezza,"

Presentaciones similares

Ablation of frequent PVC in patients meeting criteria for primary prevention ICD implant: Safety of withholding the implant Diego Penela, MD, Juan Acosta,

Ablation of frequent PVC in patients meeting criteria for primary prevention ICD implant: Safety of withholding the implant Diego Penela, MD, Juan Acosta,
Effectiveness of mycophenolate mofetil in C3 glomerulonephritis Cristina Rabasco, Teresa Cavero, Elena Román, Jorge Rojas-Rivera, Teresa Olea, Mario Espinosa,

Effectiveness of mycophenolate mofetil in C3 glomerulonephritis Cristina Rabasco, Teresa Cavero, Elena Román, Jorge Rojas-Rivera, Teresa Olea, Mario Espinosa,
HLA-DRB1*15:01 allele protects from asthma susceptibility María Pino-Yanes, PhD, Almudena Corrales, CLT, Marialbert Acosta-Herrera, MSc, Eva Pérez-Rodríguez,

HLA-DRB1*15:01 allele protects from asthma susceptibility María Pino-Yanes, PhD, Almudena Corrales, CLT, Marialbert Acosta-Herrera, MSc, Eva Pérez-Rodríguez,
The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer Eva Ciruelos, Tomás Pascual, María Luisa.

The therapeutic role of fulvestrant in the management of patients with hormone receptor-positive breast cancer Eva Ciruelos, Tomás Pascual, María Luisa.
Novel Genomic Imbalances in B-Cell Splenic Marginal Zone Lymphomas Revealed by Comparative Genomic Hybridization and Cytogenetics Jesús María Hernández,

Novel Genomic Imbalances in B-Cell Splenic Marginal Zone Lymphomas Revealed by Comparative Genomic Hybridization and Cytogenetics Jesús María Hernández,
Severe contiguous perianal Crohn's disease Tricie K. Toledo, MD, Helena R. Camasmie, MD, Carlos A.F. Athayde, MD, Ricardo B. Lima, MD, Antonio M. D'Acri,

Severe contiguous perianal Crohn's disease Tricie K. Toledo, MD, Helena R. Camasmie, MD, Carlos A.F. Athayde, MD, Ricardo B. Lima, MD, Antonio M. D'Acri,
Crohn's disease and cheilitis granulomatosa: Role of silicone fillers Helena Álvarez-Garrido, MD, Laura Pericet-Fernández, MD, Gerardo Martínez-García,

Crohn's disease and cheilitis granulomatosa: Role of silicone fillers Helena Álvarez-Garrido, MD, Laura Pericet-Fernández, MD, Gerardo Martínez-García,
Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the.

Global, regional, and national age–sex specific all-cause and cause-specific mortality for 240 causes of death, 1990–2013: a systematic analysis for the.
Análisis de Minimización de Costo e Impacto Presupuestario del Tratamiento ARV con Abacavir/Lamivudina para el VIH/SIDA en México  Kely Rely, MD, MPH,

Análisis de Minimización de Costo e Impacto Presupuestario del Tratamiento ARV con Abacavir/Lamivudina para el VIH/SIDA en México  Kely Rely, MD, MPH,
Incidence, Risk Factors, and Outcome of Cytomegalovirus Infection and Disease in Patients Receiving Prophylaxis with Oral Valganciclovir or Intravenous.

Incidence, Risk Factors, and Outcome of Cytomegalovirus Infection and Disease in Patients Receiving Prophylaxis with Oral Valganciclovir or Intravenous.
Volume 16, Issue 6, Pages (June 2014)

Volume 16, Issue 6, Pages (June 2014)
HLA-DRB1*15:01 allele protects from asthma susceptibility

HLA-DRB1*15:01 allele protects from asthma susceptibility
Estimating Preferences for Treatments in Patients With Localized Prostate Cancer  Mónica Ávila, MPH, Virginia Becerra, MPH, Ferran Guedea, MD, PhD, José.

Estimating Preferences for Treatments in Patients With Localized Prostate Cancer  Mónica Ávila, MPH, Virginia Becerra, MPH, Ferran Guedea, MD, PhD, José.
Volume 11, Issue 3, Pages (January 2009)

Volume 11, Issue 3, Pages (January 2009)
Volume 14, Issue 5, Pages S43-S47 (July 2011)

Volume 14, Issue 5, Pages S43-S47 (July 2011)
Volume 14, Issue 5, Pages S65-S70 (July 2011)

Volume 14, Issue 5, Pages S65-S70 (July 2011)
Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Chronic Graft- versus-Host Disease  Fernanda N. Villanueva, Jose Antonio Pérez-Simón,

Oral Beclomethasone Dipropionate for the Treatment of Gastrointestinal Chronic Graft- versus-Host Disease  Fernanda N. Villanueva, Jose Antonio Pérez-Simón,
A Primary Care–Based Randomized Controlled Trial of 12-Week Whole-Body Vibration for Balance Improvement in Type 2 Diabetes Mellitus  Jesús del Pozo-Cruz,

A Primary Care–Based Randomized Controlled Trial of 12-Week Whole-Body Vibration for Balance Improvement in Type 2 Diabetes Mellitus  Jesús del Pozo-Cruz,
Volume 121, Issue 4, Pages (April 2002)

Volume 121, Issue 4, Pages (April 2002)
Hallmarks of Cancer: The Next Generation Douglas Hanahan, Robert A. Weinberg Cell Volume 144, Issue 5, Pages (March 2011) DOI: /j.cell

Hallmarks of Cancer: The Next Generation Douglas Hanahan, Robert A. Weinberg Cell Volume 144, Issue 5, Pages (March 2011) DOI: /j.cell

Presentaciones similares

Anuncios Google